ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ViaCyte, Gore to Develop Technologies that Enhance Delivery of Therapies for Diabetes
March 05, 2021ViaCyte and W. L. Gore & Associates announced the two companies have signed an expanded joint development agreement covering the development and use of proprietary Gore materials and device capabilities to further optimize ViaCyte's portfolio of ... -
ViaCyte Announces Initiation of Encapsulated Cell Therapy Study for Type 1 Diabetes
February 08, 2021ViaCyte announced that the first type 1 diabetes (T1D) patients have been implanted in a Phase 2 clinical study utilizing encapsulated delivery of cells. -
Center for Beta Cell Therapy in Diabetes, ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants
January 23, 2019The Center for Beta Cell Therapy in Diabetes and ViaCyte announced a human stem cell-derived product candidate has been implanted in type 1 diabetes patients at a subtherapeutic dose..... -
ViaCyte Secures $80 Million Financing for Insulin-Requiring Diabetes
December 03, 2018Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor
Pharma Sources Insight January 2025
